Delgado, C.; Nogara, P.A.; Miranda, M.D.; Rosa, A.S.; Ferreira, V.N.S.; Batista, L.T.; Oliveira, T.K.F.; Omage, F.B.; Motta, F.; Bastos, I.M.;
et al. In Silico and In Vitro Studies of the Approved Antibiotic Ceftaroline Fosamil and Its Metabolites as Inhibitors of SARS-CoV-2 Replication. Viruses 2025, 17, 491.
https://doi.org/10.3390/v17040491
AMA Style
Delgado C, Nogara PA, Miranda MD, Rosa AS, Ferreira VNS, Batista LT, Oliveira TKF, Omage FB, Motta F, Bastos IM,
et al. In Silico and In Vitro Studies of the Approved Antibiotic Ceftaroline Fosamil and Its Metabolites as Inhibitors of SARS-CoV-2 Replication. Viruses. 2025; 17(4):491.
https://doi.org/10.3390/v17040491
Chicago/Turabian Style
Delgado, Cássia, Pablo Andrei Nogara, Milene Dias Miranda, Alice Santos Rosa, Vivian Neuza Santos Ferreira, Luisa Tozatto Batista, Thamara Kelcya Fonseca Oliveira, Folorunsho Bright Omage, Flávia Motta, Izabela Marques Bastos,
and et al. 2025. "In Silico and In Vitro Studies of the Approved Antibiotic Ceftaroline Fosamil and Its Metabolites as Inhibitors of SARS-CoV-2 Replication" Viruses 17, no. 4: 491.
https://doi.org/10.3390/v17040491
APA Style
Delgado, C., Nogara, P. A., Miranda, M. D., Rosa, A. S., Ferreira, V. N. S., Batista, L. T., Oliveira, T. K. F., Omage, F. B., Motta, F., Bastos, I. M., Orian, L., & Rocha, J. B. T.
(2025). In Silico and In Vitro Studies of the Approved Antibiotic Ceftaroline Fosamil and Its Metabolites as Inhibitors of SARS-CoV-2 Replication. Viruses, 17(4), 491.
https://doi.org/10.3390/v17040491
